The neurotropic a-herpesviruses are common mammalian pathogens that invade the peripheral and central nervous system of their hosts. Their ability to invade and spread in the nervous system in a directional manner has been exploited to develop them as neuronal circuit tracers. Tracing viruses spread among synaptically connected neurons and, by assaying brain sections for viral antigen or reporter genes expressed from the viruses, chains of synaptically connected neurons can be visualized. Virulent field strains generally are not good tracers, but some attenuated strains perform well. Live attenuated vaccine strains of pseudorabies virus (PRV), such as PRV Bartha, are among the most popular virus circuit tracers. It may be counterintuitive that attenuation results in improved neural tracing that requires extensive replication and spread in the brain. This report summarizes two lines of experiments directed to resolving this apparent paradox and introduces a new paradigm for tracing viruses.
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a-Herpesviruses, such as herpes simplex virus types 1 and 2, varicella-zoster virus, and pseudorabies virus (PRV), are novel parasites of their host's peripheral nervous system (PNS) (see [1] [2] [3] ). This tropism for the PNS is remarkable because the viruses are pantropic, capable of engaging multiple receptors and of infecting most cells in the body. In fact, many aspects of aherpesvirus pathogenesis reflect this broad range of cell tropism. However, during infections of a healthy natural host, the primary infection is resolved and viruses invariably invade the PNS where they establish their genomes as quiescent extra chromosomes in neurons in peripheral ganglia (the latent state). Reactivation from latency is associated with viral replication in the primary neuron followed by anterograde transport of newly synthesized virus particles from the neuronal cell body back to the innervated tissue. Although less frequent, virus may also spread from the PNS to the central nervous system (CNS) following primary infection or reactivation with serious, often fatal, consequences for the host. This directional movement of virus to PNS cell bodies during infection and away from the cell bodies during reactivation is noteworthy and suggests that viral genes control direction (reviewed in [4] ). Similarly, the relative, but not absolute, inability to cross into the CNS in the natural host, but not in permissive alternative hosts, is of considerable interest.
The ability of viruses like PRV to spread efficiently from the Protocols were approved by the Princeton University Animal Welfare Committee and were consistent with regulations of the American Association for Accreditation of Laboratory Animal Care and of the Animal Welfare Act (public law PNS to CNS upon infection of many nonnatural hosts was recognized over 60 years ago and signaled the possibility of use to trace neuronal connections [5] [6] [7] . In recent years, Kuypers, Kristensson, Dolivo, Stevens, and others pioneered techniques of using viruses that infect the brain as tracers of neuronal connections (reviewed in [1] ; see also [8] ). Although both human and animal neurotropic herpesvirus strains have been successfully used for this type of analysis, the most extensive and well-characterized studies have utilized PRV.
The broad host range of PRV includes swine (its natural host), cattle, rodents, cats, dogs, rabbits, and chicken embryos (but not higher primates, including humans). The availability of attenuated strains such as PRV Bartha and other well-defined viral mutants and reporter viruses have made PRV an attractive tool for characterization of both neuronal circuitry and virus-induced pathogenesis in a variety of animal models. A major question is obvious: Why is the Bartha strain of PRV such a good tracer of neuronal connections? In this report, I summarize two studies that provided unexpected insight and some answers to this question. In addition, I describe a new generation of PRV tracing vectors that may be of value for studies of viral pathogenesis.
Materials and Methods
Methods are described in reports by Whealy et al. [9] , Card et al. [10] , Smith et al. [11] , Tomishima and Enquist [12] , and DeFalco et al. [13] . The general protocol for tracing experiments, tissue processing, and antigen detection has been described [14] . All virus experiments were performed under biosafety level two conditions.
Results
Increased survival can result in more CNS spread. A tracing virus must replicate and spread extensively in the nervous system, but animals must survive long enough for spread to occur. This requirement seems counter-intuitive. How can extensive transneuronal spread in the nervous system be compatible with survival? For some, it has been a foregone conclusion that spread in the CNS is the prime reason for death after PRV infection. Similar logic suggests that attenuated viruses must have reduced or no replication in the CNS. Obviously, circuittracing strains of PRV replicate well in the nervous system. The first clue for understanding this apparent paradox is that the best tracing strain of PRV is not a wild type virus.
Wild type viruses are particularly ineffective tracers of neuronal connections simply because they kill animals before extensive neuronal spread occurs. In fact, our best tracing viruses are derivatives of attenuated live vaccine PRV strains developed more than 40 years ago for the swine industry. These live vaccine strains were not genetically engineered but were selected to grow well in culture, be stable in the field, and to produce good immunity without disease in swine. They have proven to be effective in almost eliminating PRV as an agricultural pathogen. These vaccine strains also have become "gold mines" for viral geneticists as they contain a variety of mutations, many uncharacterized, that reduce virulence while maintaining the ability to infect and initiate an immune response. By identifying and studying the attenuating mutations in vaccine strains, we have learned that several PRV genes promote characteristic symptoms of infection and early death of animals (see [15] [16] [17] ). When these genes are deleted from wild type virulent viruses, animals live longer and their symptoms are reduced, but the viruses still replicate as well as wild type virus. These mutants also are excellent tracing viruses and spread extensively in the brain (reviewed in [1, 8, 18] ).
A key mutation in PRV Bartha is a single deletion that removes 3 viral membrane protein genes, gE, gI, and Us9. None of these genes is required for virus growth in cell lines and all are conserved in the a-herpesvirus subfamily. One of these genes encodes the gE membrane protein (reviewed in [19] ). Yang et al. [18] found that wild type PRV efficiently invades the rat CNS after infection of the stomach musculature and spreads by retrograde transport in axons of the vagus nerve, but animals die before virus can spread from the brain stem to synaptically connected nuclei. In contrast, animals infected with the PRV Bartha strain live almost twice as long and virus spreads from the brainstem to synaptically connected nuclei in the forebrain. Deletion of gE from the wild type virus results in an attenuated mutant that produces markedly reduced symptoms of infection and animals live almost twice as long as those infected by the parent virus. Of importance, gE null viruses spread almost as extensively in the vagus circuitry as PRV Bartha, one of the best tracing strains. The implications for pathogenesis are not understood in detail but an unanticipated conclusion is that while both wild type PRV and PRV Bartha kill animals, wild type virus kills rapidly by a different mechanism that requires gE. PRV Bartha kills slowly in a gE-independent fashion. Tirabassi and I [20] mapped the virulence function of gE to its cytoplasmic tail. No further understanding of this virulence function has emerged to date (discussed in [14, [20] [21] [22] [23] ).
Tracing viruses spread in the retrograde, not anterograde, direction in a circuit. Those who study herpesvirus spread in the nervous system often use the words "retrograde" and "anterograde" to describe direction. Unfortunately, confusion arises because the terms can be used to describe directional movement of virus inside a cell as well as spread of virus between synaptically connected neurons (figure 1). Another way to think about anterograde and retrograde movement between neurons in a circuit is in terms of viral egress. During anterograde movement between neurons, viral egress occurs at axon terminals (egress from the presynaptic cell and entry into the postsynaptic cell). Retrograde movement to a synaptically connected neuron on the other hand requires viral egress from the cell body or dendrites of a neuron (egress from the postsynaptic cell dendrites or cell body and entry into the axon of the presynaptic cell).
The best PRV tracing strains are retrograde tracers: They spread from postsynaptic infected neurons to presynaptic uninfected neurons in a neural circuit (figure 1). To my knowledge, PRV Bartha cannot spread from presynaptic infected neurons to synaptically connected postsynaptic neurons (see [24] ). An obvious question is why Bartha has this remarkable directional spread deficit. Bartha was selected as a live attenuated vaccine strain-it could replicate well in culture and it could replicate in swine sufficient to induce protective immunity and produce modest symptoms after acute infection. In addition, viral shedding from vaccinated animals was reduced or absent (reviewed in [15] ). There was no overt attempt to select a virus with deficits in directional spread in and between neurons.
It now appears that reduced virulence reflects multiple mutations, but a single deletion affects both virulence and directional spread [15] . Mutations in any 1 of 3 contiguous Us genes (gE, gI, Us9) block anterograde spread of PRV in a neuronal Figure 2 . Mutants lacking either gE, gI, or Us9 cannot spread from the presynaptic cell to postsynaptic cell. Models depict stylized neuron with a single axon extending from the cell body. A, Anterograde spread requires that virus enter axons (restricted compartment) and travel long distances by using plus-end microtubule motors (kinesis family). gE, gI, and Us9 mutants could affect entry into the axon and transport or affect egress from axon terminal (arrows). B, Data suggest that Us9 functions by enabling virus membrane proteins, but not capsid or 2 tegument proteins, into axons; gE mutants lack this phenotype. Thus, gE and gI may function at axon terminal to effect egress. Figure 3 . Models for anterograde spread of virus focus on virus entry into the axon. A, Mature virus is assembled in the cell body and then captured in a host vesicle that moves the intact mature virion in the axon to the terminus for release. Egress from soma and dendrites occurs by the same mechanism. B, Cunningham model as expanded by work with Us9 mutants. Virion subassemblies are inserted into neurons and moved separately to axon terminal for assembly. Us9 is required to move vesicles carrying virus envelope proteins. Assembled capsid proteins enter axon in Us9-independent fashion. A viral protein likely is required to give license to capsids for axon entry, but this putative protein has not been identified. Tegument proteins have not been studied extensively but UL25 and UL49 enter axons in Us9-independent manner. Some tegument proteins likely associate with capsids and others with membrane protein vesicles, but this possibility has not been tested. Current understanding of a-herpesvirus assembly in nonneuronal cells is reviewed in [32] .
circuit (no spread from presynaptic infected neuron to postsynaptic uninfected neuron [9, [25] [26] [27] . Restoration of these genes to PRV Bartha revives virulence and its ability to spread in the anterograde direction [15, 16] .
How do gE, gI, and Us9 affect directional spread? The mutants grow well in tissue culture cells, primary neurons, and brains of rodents and chicken embryos with no significant defects in virus gene expression or replication. Therefore, gE, gI, and Us9 may act at the axon terminal to promote exit of virions or in the cell body to promote virion entry into axons ( figure  2A) . Recently, a colleague and I [12] discovered that Us9 acts at a different step from gE and gI during virus spread in cultured neurons. Us9 is an abundant 98-aa type II membrane phosphoprotein conserved in all a-herpesviruses (except the known avian-specific viruses). In addition to being a structural protein found in virion envelopes, Us9 is found in infected cell membranes and accumulates in small vesicles in or near the trans-Golgi network [28] . The Us9 protein is required for appearance only of viral membrane proteins in axons but not of capsid or tegument proteins ( figure 2B ). This finding indicates why Us9 mutants (e.g., PRV Bartha) cannot spread to postsynaptic cells in animals: Critical membrane proteins such as gB, which are known to be required for spread from neuron to neuron [29] , do not move to axon terminals to promote viral spread in Us9 mutants. Recent work with BHV-5 demonstrates that Us9 mutants have similar phenotypes [30] . The virus is grown in standard tissue culture cell lines to high titer (typically 10 9 pfu/mL). A transgenic mouse is constructed such that Cre is expressed from a neuronal promoter defining a circuit of interest. 1. Virus is injected directly into a brain region known to contain neurons in the circuit of interest. 2. Virus enters any neuron but has a predilection to be taken up by axon terminals at the injection site. Viral capsids move to the cell body where viral replication only occurs in neurons expressing Cre. These neurons excise the lox-stop-lox DNA from PRV Ba2001; the resulting virus replicates and expresses GFP. Neurons not expressing Cre do not produce virus and are not labeled with GFP. 3. Recombinant virus (TK plus, GFP plus) now spreads to any presynaptic cell in contact with the neuron expressing Cre. These synaptically connected neurons will be infected and express GFP whether or not they express Cre. Thus, any GFP-positive cell in the brain must be considered to be in a circuit connected to the Cre-expressing neurons at the injection site. Only neurons that project axons to the Cre-expressing neurons will be infected because the virus only spreads retrograde (from postsynaptic to presynaptic neurons).
The unexpected result that Us9 enables axon localization of viral membrane proteins but not viral capsids or 2 tegument proteins was not consistent with a popular model of virus anterograde spread. The general idea was that the mature virion is assembled in the neuronal cell body and then transported in a vesicle to the terminal for release ( figure 3A) . The Us9 mutant data support and extend an alternative model proposed by Penfold et al. [31] for herpesvirus spread from sensory neurons to epithelial cells ( figure 3B ). In this view, viral membrane proteins not only are transported separately from capsids in axons but also specific viral proteins regulate transport of capsid and membrane proteins. The questions are under study of where assembly of envelope, tegument, and capsid virion components occurs so that infection can spread to the postsynaptic neuron [2, 32] .
Controlled infection: a new tracing paradigm. While PRV Bartha derivatives have proven utility as tracers, they apparently infect all neurons and thus have limited utility for deciphering specific neuronal circuits, particularly in the CNS where multiple circuits are interleaved and intertwined. My colleagues and I [13] constructed a conditional PRV tracing strain that replicates only in specific neurons. The method is based on Crelox recombination and requires two general components: a virus that requires Cre-promoted recombination to grow and transgenic mice that express Cre under control of specific neuronal promoters. We constructed a PRV Bartha derivative called Ba2001 that is dependent on a Cre-mediated recombination event for expression of an essential viral gene (thymidine kinase [TK] ) as well as green fluorescent protein (GFP) (figure 4A). TK is required for virus growth in nondividing cells (e.g., neurons) but is not required for growth in mitotic cells (e.g., transformed tissue culture cells). PRV Ba2001 cannot replicate or express GFP in non-Cre-expressing neurons but becomes permanently replication competent and expresses GFP when it infects a neuron expressing Cre ( figure 4B ).
With the use of viruses such as PRV Ba2001, precise control of infection is possible. The underlying value of this system may be that a virus can be constructed capable of reporting where it has been. Cre is but one of a large family of sitespecific recombinases recognizing short defined DNA sequences. Similarly, fluorescent proteins come in many colors. One can imagine building viruses with several color reporter expression cassettes flanked by different recombination sequences set to be activated when the virus enters a cell expressing any of the various recombinases. Combinations of recombinases and reporters flanked by recombination sites provide new possibilities not only to control but also to monitor herpesviruses (or any virus amenable to recombinant DNA technology) as they move through various cell types in infected transgenic animals.
Discussion
Several conclusions can be drawn from the work summarized. First, PRV gene gE dramatically affects animal survival and its deletion improves circuit-tracing ability. The mechanism by which the cytoplasmic tail domain of gE promotes rapid symptoms and early death is under study. Second, the deletion of any 1 of 3 genes (gE, gI, Us9) from wild type PRV blocks anterograde spread of infection (from presynaptic to postsynaptic neurons). Us9 mutants apparently are defective in anterograde spread in neural circuits because essential viral membrane proteins such as gB are not transported to axon terminals to facilitate spread to the connected neuron. In contrast, gE and gI mutants manifest their phenotype because these proteins most likely function at the axon terminal of the infected neuron to promote spread. It is clear that the normal life cycle of the a-herpesviruses demands precise control of directional spread in the nervous system, and this is manifested in the novel assembly and transport mechanisms of anterograde spread. Finally, a tracing virus was engineered that can replicate only in cells that express the Cre-recombinase. When injected into the brains of transgenic mice expressing Cre from defined neuronal promoters, it is possible to trace the neurons in synaptic contact with the Cre-expressing neuron. This class of tracing virus introduces technology to build viruses capable of reporting where they have been in a living animal. Precise control of infection is possible and should prove valuable in studies with many other viruses amenable to genetic manipulation.
